Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 18 of 18 for “"Virus-like Particles (VLP)"”.
-
Investigation of molecular mechanisms of macrophage activation /
… protofibrils; filamentous N proteins of paramyxoviruses; spherical virus-like particles (VLP) of polyomaviruses. We measured inflammatory cytokine secretion and NLRP3 inflammasome activation by assessing IL-1β secretion, caspase-1 activation and formation of ASC specks. We found that both Aβ …
-
Developing a Virus-Like Particle (VLP)-Based Vaccine for Neisseria gonorrhoeae
… Ng epitopes on the surface of bacteriophage virus-like particles (VLP). VLPs are immunogenic, multivalent, self-assembling complexes composed of viral structural proteins. Antigenic peptide sequences can be displayed on the surface of VLPs via chemical conjugation or genetic insertion …
-
Role of the Ebolavirus Glycoprotein in Countering Tetherin During Viral Budding
Ebola virus (EBOV) is the causative agent of Ebola virus hemorrhagic fever and initiates sporadic outbreaks with very high mortality rates of up to 90%. The only viral surface protein on EBOV virions, the EBOV Glycoprotein (GP1,2), is a known antagonist of the intrinsic innate immune effector …
-
Evaluation of methods for generating Senecavirus A virus-like particles utilizing the baculovirus expression vector system
… subunit vaccine against Seneca Valley virus (SVV) would be valuable to the swine industry. Recent SVV outbreaks have raised concerns with national biosecurity. This is due to the potential of foreign vesicular animal diseases entering the United States undetected because of confounding …
-
Structure-guided optimization of immunogens for emerging arthropod-borne viruses
<p>Mosquito-borne arboviruses, such as flaviviruses and alphaviruses cause millions of infections every year and raise public health concerns worldwide, yet, there are no approved vaccines or specific treatments for the majority of them. There is also an urgent need for improved diagnostics and …
-
Exploring the Role of Human Endogenous Retroviral Gag in the Formation and Content of Extracellular Vesicles
Human Endogenous Retroviruses (HERV) are derived from exogenous retroviruses that infected inheritable germline tissues millions of years ago and account for 8% of the human genome. Like other retroviruses HERVs encode Gag, Pol and sometimes Env proteins. During a retroviral infection, retroviral …
-
Implication des cellules Natural Killer (NK) dans le développement des lésions associées à l'infection par les papillomavirus humains (HPV)
Persistent infections with high-risk papillomavirus (HPV) are associated with more than 25% of cancers induced by infectious agents. Nevertheless, the two vaccines preventing HPV infection have no therapeutic efficacy and it has been estimated that there will be no measurable decline of …
-
P22 virus templated synthesis of plasmonic photocatalytic nanostructures
… in the biotemplated synthesis of inorganic nanoparticles, did not produce better outcome compared to direct reduction without protein/gold precursor interaction. Genetically engineered scaffolding proteins evenly positioned inside P22 virus-like particles (VLP) can act as selective biotemplates …
-
DEVELOPMENT OF PREVENTIVE VACCINES TARGETING ALPHA AND BETA HUMAN PAPILLOMAVIRUSES FOR CANCER PREVENTION
Human papillomaviruses (HPV) are small, double stranded, non-enveloped DNA tumor viruses that infect mucosal and cutaneous epithelia. Infections of mucosal epithelia with high and intermediate risk αHPV types are associated with cervical, ano-genital and oropharyngeal cancers whereas low risk types …
-
Developing SINrep5 as a Viral Vector Platform to Test SARS-CoV-2 Vaccine Candidates
… One particular vaccine of interest is the adenovirus vector-based vaccine, which has raised apprehension since its use against SARS-CoV-2. Public hesitation and unclear human-use risks surrounding adenovirus vector vaccines have warranted exploration into other vectors—not just as ready-for-use …
-
Novel fluorescence and fluorine labelling methods for viruses and virus-like particles
… the development of novel labelling methods for viruses or virus-like particles with specific applications.</p> <p>Virus-like particles (VLP) derived from the <em>E. coli</em> bacteriophage Qβ are widely employed as a nano-carrier for drugs and vaccines, but a powerful method for tracing its …
-
Clonagem molecular e expressão em Pichia pastoris do gene L1 de papilomavírus bovino tipo 2
… ser eficientemente induzidos pela imunização com virus-like particles(VLP) que se formam espontaneamente, após a expressão de L1 em sistemas heterólogos. Nos últimos anos, a levedura metilotrófica Pichia pastoris emergiu como um sistema eficaz e barato para produzir altos níveis …
-
Plasmonic spectroscopy of biomacromolecules with chiral metamaterial
… can sense highly symmetrical structures such as viruses. In the first results chapter it will be shown that the chiral fields are highly sensitive to the surface charges of a protein. It will be shown that the surface charges of the analyte can enhance or reduce the chiral fields depending on the …
-
Novel DNA Vaccine Formulations Against Hepatitis C Virus
No vaccines are available for hepatitis C virus (HCV) which infects over 71 million people worldwide. Current therapeutic options are very expensive and as a consequence, only around 1% of those diagnosed with Hepatitis C receive treatment each year. Induction of neutralizing antibody (NAb) by …
-
Investigation of Virus-Like-Particles and Antigen-Loaded Poly-Lactic-Acid Particles for Transcutaneous Vaccine Delivery
… strategy for the delivery of large molecules and particles. However, the principal challenge is to find a vaccine compound, which is stable in the skin environment, penetrates sufficiently across the skin barrier and effectively targets resident immune cells. In this study, novel experimental …
-
Immunogenicity of antigen-displaying virus-like particles and their use as a potential vaccine against prion diseases
… to set up a new vaccination strategy based on virus-like particles (VLP) to induce anti-PrPC antibody responses in PrPC-competent mice. In a first step it was assessed whether VLP have the capacity to induce antibody responses that are protective against conventional pathogens. For this …
-
Virus-ähnliche Partikel auf Basis des Hamster-Polyomavirus als potentielle Träger für den Gentransfer
… Therapie von Krebserkrankungen und chronischen Virusinfektionen eingeführt. Zur Übertragung des Transgens sind unterschiedliche in vivo-, ex vivo- und in vitro-Verfahren entwickelt worden, die unterschiedliche Vor- und Nachteile hinsichtlich Verpackungskapazität, Immunität, Applikationsweise und …
-
Optimized Production and Purification of LCC DNA Minivectors for Applications in Gene Therapy and Vaccine Development
… for downstream development of a HIV DNA-VLP (Virus-like particle) vaccine, thus highlighting the capacity of such system to produce DNA ministrings with numerous potential applications.